Intravenous (IV) Solutions Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1064221
  • May 2021
  • Pharmaceuticals
  • 120 Pages
The Intravenous (IV) Solutions market research report provides an in-depth analysis of the currents trends, latest developments, scenario, market size, various drivers, restraints, and major players along with their profile details. Research report offers the historic data for year 2018 and 2019 and also provides the forecast data from year 2020 to 2028 which is based on revenue (USD Million). With the help of all these information research report helps the market participants to improve market positions. With the help of all these insights Intravenous (IV) Solutions market research report recommends a business strategy for present market participants to strengthen their position in the market.
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered Baxter International Inc., ICU Medical, Inc., Grifols, S.A., B. Braun Melsungen AG, Fresenius Kabi, Amanta Healthcare, JW Life Science, Soxa Formulations and Research (Pvt.) Ltd, AXA Parenterals Ltd., Otsuka Pharmaceutical Co., Ltd
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Impact Analysis
The analysis of covid-19 is based on the impact of the current pandemic situation on market scenarios. This includes impact of covid-19 outbreak on overall revenue, market segments as well as regional market. The report also puts light on detailed impact analysis by taking into consideration all the government policies imposed during the pandemic situation, temporary shutdown of manufacturing units, current state of supply chain and distributors, and its future impacts on the growth of overall market. The market study will assist user to understand the global demand and impose strategic business plans to compete with the peers.

Furthermore, the research report includes the detailed information about major players and provides the data regarding the current market scenario as well as upcoming market opportunities or challenges. Similarly, in segment report covers the types, and applications according to the countries and key regions. The research report consists the various drivers and restraints for Intravenous (IV) Solutions market along with their effects over the forecast period. Similarly, according to the region Intravenous (IV) Solutions market research report includes the study of opportunities available in the market situation.

The Intravenous (IV) Solutions market research report provides the in-depth data analysis by using the various graphs, figures, charts, and tables. Furthermore, the report provides the different business challenges which are impacting market growth in all direction.

Major Key Players for Global Intravenous (IV) Solutions Market:
The Intravenous (IV) Solutions market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Baxter International Inc., ICU Medical, Inc., Grifols, S.A., B. Braun Melsungen AG, Fresenius Kabi, Amanta Healthcare, JW Life Science, Soxa Formulations and Research (Pvt.) Ltd, AXA Parenterals Ltd., Otsuka Pharmaceutical Co., Ltd

Intravenous (IV) Solutions Market Segmentation Analysis:
By Solution
Saline
Dextran
Lactated Ringer\'s
Amino Acid
Vitamins and Minerals
Heparin and Trace Elements
Mixed Solutions
Bag Type
Large Volume Bags
Small Volume Bags
End-user
Hospitals and Clinics
Ambulatory Surgery Centers
Home Care Settings


Global Intravenous (IV) Solutions Market Segmentation by Regions:
In regional analysis, Intravenous (IV) Solutions market research report provides the detailed analysis from various regions and also contains the detailed analysis of country. Along with market revenue, market value report also offers the forecast analysis for the following countries and regions. Global Intravenous (IV) Solutions market report covers the various geographical regions such as North America, Asia-Pacific, Europe, Latin America, and Middle East & Africa. Also, various countries included are Canada, U.K., France, the U.S., Japan, China, India, and Germany and so on.

North America Region for Intravenous (IV) Solutions Market: Value and Forecast
  • U.S.
  • Canada
 Europe Region for Intravenous (IV) Solutions Market: Value and Forecast
  • UK
  • Germany
  • France
  • Rest of the Europe
 Asia Pacific Region for Intravenous (IV) Solutions Market: Value and Forecast
  • China
  • Japan
  • India
  • Rest of the Asia Pacific
 Latin America Region for Intravenous (IV) Solutions Market: Value and Forecast
  • Mexico
  • Brazil
  • Rest of the Latin America
 Middle East and Africa for Intravenous (IV) Solutions Market: Value and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa


Important Points Covered by Report:
  • To analyze the value of the Intravenous (IV) Solutions market, according to the key region.
  • To study the Intravenous (IV) Solutions market current trends, prospects and also their participation in the entire sector.
  • Report consists the in-depth information related to the region/countries, major key players, current trends and their analysis, product type, applications, and other background information
  • Report provides the detailed information about drivers, restraints and future scope of Intravenous (IV) Solutions market.
  • Report covers the information about historic data analysis as well as forecast period analysis.

Global Intravenous (IV) Solutions research report consist the information about overall sales and revenue during the historic and forecasted period of 2018 to 2028. Additionally, this report covers the inside and out factual examination and the market elements and requests which give an entire situation of the business.

Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Intravenous (IV) Solutions market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Intravenous (IV) Solutions market for numerous purposes such as:

    1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

     2. Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Intravenous (IV) Solutions market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Intravenous (IV) Solutions market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

     3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Intravenous (IV) Solutions market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • Baxter International Inc.
  • ICU Medical, Inc.
  • Grifols, S.A.
  • B. Braun Melsungen AG
  • Fresenius Kabi
  • Amanta Healthcare
  • JW Life Science
  • Soxa Formulations and Research (Pvt.) Ltd
  • AXA Parenterals Ltd.
  • Otsuka Pharmaceutical Co., Ltd
  • Saline
  • Dextran
  • Lactated Ringer's
  • Amino Acid
  • Vitamins and Minerals
  • Heparin and Trace Elements
  • Mixed Solutions
  • Hospitals and Clinics
  • Ambulatory Surgery Centers
  • Home Care Settings

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Intravenous (IV) Solutions Market Snapshot
          2.1.1. Global Intravenous (IV) Solutions Market By Solution,2019
               2.1.1.1.Saline
               2.1.1.2.Dextran
               2.1.1.3.Lactated Ringer's
               2.1.1.4.Amino Acid
               2.1.1.5.Vitamins and Minerals
               2.1.1.6.Heparin and Trace Elements
               2.1.1.7.Mixed Solutions
          2.1.2. Global Intravenous (IV) Solutions Market By End-user,2019
               2.1.2.1.Hospitals and Clinics
               2.1.2.2.Ambulatory Surgery Centers
               2.1.2.3.Home Care Settings
          2.1.3. Global Intravenous (IV) Solutions Market By End-use,2019
          2.1.4. Global Intravenous (IV) Solutions Market By Geography,2019

3. Global Intravenous (IV) Solutions Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Intravenous (IV) Solutions Market Size (US$), By Solution, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Solution, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Solution, 2020
     4.2. Global Intravenous (IV) Solutions Market Size (US$), By Solution, 2018 – 2028

5. Global Intravenous (IV) Solutions Market Size (US$), By End-user, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By End-user, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By End-user, 2020
     5.2. Global Intravenous (IV) Solutions Market Size (US$), By End-user, 2018 – 2028

6. Global Intravenous (IV) Solutions Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Intravenous (IV) Solutions Market Size (US$), By End-use, 2018 – 2028

7. Global Intravenous (IV) Solutions Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Intravenous (IV) Solutions Market Analysis, 2018 – 2028 
          7.2.1. North America Intravenous (IV) Solutions Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Intravenous (IV) Solutions Market Size (US$), By Solution, 2018 – 2028
          7.2.3. North America Intravenous (IV) Solutions Market Size (US$), By End-user, 2018 – 2028
          7.2.4. North America Intravenous (IV) Solutions Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Intravenous (IV) Solutions Market Analysis, 2018 – 2028 
          7.3.1.  Europe Intravenous (IV) Solutions Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Intravenous (IV) Solutions Market Size (US$), By Solution, 2018 – 2028
          7.3.3. Europe Intravenous (IV) Solutions Market Size (US$), By End-user, 2018 – 2028
          7.3.4. Europe Intravenous (IV) Solutions Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Intravenous (IV) Solutions Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Intravenous (IV) Solutions Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Intravenous (IV) Solutions Market Size (US$), By Solution, 2018 – 2028
          7.4.3. Asia Pacific Intravenous (IV) Solutions Market Size (US$), By End-user, 2018 – 2028
          7.4.4. Asia Pacific Intravenous (IV) Solutions Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Intravenous (IV) Solutions Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Intravenous (IV) Solutions Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Intravenous (IV) Solutions Market Size (US$), By Solution, 2018 – 2028
          7.5.3. Latin America Intravenous (IV) Solutions Market Size (US$), By End-user, 2018 – 2028
          7.5.4. Latin America Intravenous (IV) Solutions Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Intravenous (IV) Solutions Market Analysis, 2018 – 2028 
          7.6.1.  MEA Intravenous (IV) Solutions Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Intravenous (IV) Solutions Market Size (US$), By Solution, 2018 – 2028
          7.6.3. MEA Intravenous (IV) Solutions Market Size (US$), By End-user, 2018 – 2028
          7.6.4. MEA Intravenous (IV) Solutions Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Intravenous (IV) Solutions Providers
        8.4.1 Baxter International Inc.
                8.4.1.1 Business Description
                8.4.1.2 Baxter International Inc. Geographic Operations
                8.4.1.3 Baxter International Inc. Financial Information
                8.4.1.4 Baxter International Inc. Product Positions/Portfolio
                8.4.1.5 Baxter International Inc. Key Developments
        8.4.2 ICU Medical, Inc.
                8.4.2.1 Business Description
                8.4.2.2 ICU Medical, Inc. Geographic Operations
                8.4.2.3 ICU Medical, Inc. Financial Information
                8.4.2.4 ICU Medical, Inc. Product Positions/Portfolio
                8.4.2.5 ICU Medical, Inc. Key Developments
        8.4.3 Grifols, S.A.
                8.4.3.1 Business Description
                8.4.3.2 Grifols, S.A. Geographic Operations
                8.4.3.3 Grifols, S.A. Financial Information
                8.4.3.4 Grifols, S.A. Product Positions/Portfolio
                8.4.3.5 Grifols, S.A. Key Developments
        8.4.4 B. Braun Melsungen AG
                8.4.4.1 Business Description
                8.4.4.2 B. Braun Melsungen AG Geographic Operations
                8.4.4.3 B. Braun Melsungen AG Financial Information
                8.4.4.4 B. Braun Melsungen AG Product Positions/Portfolio
                8.4.4.5 B. Braun Melsungen AG Key Developments
        8.4.5 Fresenius Kabi
                8.4.5.1 Business Description
                8.4.5.2 Fresenius Kabi Geographic Operations
                8.4.5.3 Fresenius Kabi Financial Information
                8.4.5.4 Fresenius Kabi Product Positions/Portfolio
                8.4.5.5 Fresenius Kabi Key Developments
        8.4.6 Amanta Healthcare
                8.4.6.1 Business Description
                8.4.6.2 Amanta Healthcare Geographic Operations
                8.4.6.3 Amanta Healthcare Financial Information
                8.4.6.4 Amanta Healthcare Product Positions/Portfolio
                8.4.6.5 Amanta Healthcare Key Developments
        8.4.7 JW Life Science
                8.4.7.1 Business Description
                8.4.7.2 JW Life Science Geographic Operations
                8.4.7.3 JW Life Science Financial Information
                8.4.7.4 JW Life Science Product Positions/Portfolio
                8.4.7.5 JW Life Science Key Developments
        8.4.8 Soxa Formulations and Research (Pvt.) Ltd
                8.4.8.1 Business Description
                8.4.8.2 Soxa Formulations and Research (Pvt.) Ltd Geographic Operations
                8.4.8.3 Soxa Formulations and Research (Pvt.) Ltd Financial Information
                8.4.8.4 Soxa Formulations and Research (Pvt.) Ltd Product Positions/Portfolio
                8.4.8.5 Soxa Formulations and Research (Pvt.) Ltd Key Developments
        8.4.9 AXA Parenterals Ltd.
                8.4.9.1 Business Description
                8.4.9.2 AXA Parenterals Ltd. Geographic Operations
                8.4.9.3 AXA Parenterals Ltd. Financial Information
                8.4.9.4 AXA Parenterals Ltd. Product Positions/Portfolio
                8.4.9.5 AXA Parenterals Ltd. Key Developments
        8.4.10 Otsuka Pharmaceutical Co., Ltd
                8.4.10.1 Business Description
                8.4.10.2 Otsuka Pharmaceutical Co., Ltd Geographic Operations
                8.4.10.3 Otsuka Pharmaceutical Co., Ltd Financial Information
                8.4.10.4 Otsuka Pharmaceutical Co., Ltd Product Positions/Portfolio
                8.4.10.5 Otsuka Pharmaceutical Co., Ltd Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Intravenous (IV) Solutions Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Intravenous (IV) Solutions Market Revenue, By Solution, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Intravenous (IV) Solutions Market Revenue, By End-user, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Intravenous (IV) Solutions Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Intravenous (IV) Solutions Market Revenue, By Solution, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Intravenous (IV) Solutions Market Revenue, By End-user, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Intravenous (IV) Solutions Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Intravenous (IV) Solutions Market Revenue, By Solution, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Intravenous (IV) Solutions Market Revenue, By End-user, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Intravenous (IV) Solutions Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Intravenous (IV) Solutions Market Revenue, By Solution, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Intravenous (IV) Solutions Market Revenue, By End-user, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Intravenous (IV) Solutions Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Intravenous (IV) Solutions Market Revenue, By Solution, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Intravenous (IV) Solutions Market Revenue, By End-user, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Intravenous (IV) Solutions Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Intravenous (IV) Solutions: Market Segmentation 
FIG. 2 Global Intravenous (IV) Solutions Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Intravenous (IV) Solutions Market, By Solution, 2019 (US$ Mn) 
FIG. 5 Global Intravenous (IV) Solutions Market, By End-user, 2019 (US$ Mn) 
FIG. 6 Global Intravenous (IV) Solutions Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Intravenous (IV) Solutions Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Intravenous (IV) Solutions Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Intravenous (IV) Solutions Providers, 2019
FIG. 11 Global Intravenous (IV) Solutions Market Revenue Contribution, By Solution, 2019 & 2028 (Value %) 
FIG. 12 Global Intravenous (IV) Solutions Market Revenue Contribution, By End-user, 2019 & 2028 (Value %) 
FIG. 13 Global Intravenous (IV) Solutions Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Intravenous (IV) Solutions Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Intravenous (IV) Solutions Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Intravenous (IV) Solutions Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Intravenous (IV) Solutions Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Intravenous (IV) Solutions Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Intravenous (IV) Solutions market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Intravenous (IV) Solutions Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Intravenous (IV) Solutions Market Value, By Segment1, 2018 – 2028
TABLE  North America Intravenous (IV) Solutions Market Value, By Segment2, 2018 – 2028
TABLE  North America Intravenous (IV) Solutions Market Value, By Country, 2018 – 2028
TABLE  Europe Intravenous (IV) Solutions Market Value, By Segment1, 2018 – 2028
TABLE  Europe Intravenous (IV) Solutions Market Value, By Segment2, 2018 – 2028
TABLE  Europe Intravenous (IV) Solutions Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Intravenous (IV) Solutions Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Intravenous (IV) Solutions Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Intravenous (IV) Solutions Market Value, By Country, 2018 – 2028
TABLE  Latin America Intravenous (IV) Solutions Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Intravenous (IV) Solutions Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Intravenous (IV) Solutions Market Value, By Country, 2018 – 2028
TABLE  MEA Intravenous (IV) Solutions Market Value, By Segment1, 2018 – 2028
TABLE  MEA Intravenous (IV) Solutions Market Value, By Segment2, 2018 – 2028
TABLE  MEA Intravenous (IV) Solutions Market Value, By Country, 2018 – 2028
TABLE  Baxter International Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  ICU Medical, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Grifols, S.A.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  B. Braun Melsungen AG: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Fresenius Kabi: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Amanta Healthcare: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  JW Life Science: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Soxa Formulations and Research (Pvt.) Ltd: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  AXA Parenterals Ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Otsuka Pharmaceutical Co., Ltd: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Intravenous (IV) Solutions Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Intravenous (IV) Solutions Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Intravenous (IV) Solutions Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Intravenous (IV) Solutions Market, By Geography, 2019 (US$ Mn)
FIG.  Global Intravenous (IV) Solutions Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Intravenous (IV) Solutions Providers, 2016
FIG.  Global Intravenous (IV) Solutions Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Dextran Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Lactated Ringer's Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Amino Acid Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Vitamins and Minerals Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Heparin and Trace Elements Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Mixed Solutions Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Intravenous (IV) Solutions Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Ambulatory Surgery Centers Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Home Care Settings Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Intravenous (IV) Solutions Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Intravenous (IV) Solutions Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Intravenous (IV) Solutions Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Intravenous (IV) Solutions Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Intravenous (IV) Solutions Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Intravenous (IV) Solutions Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Intravenous (IV) Solutions Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Intravenous (IV) Solutions Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Intravenous (IV) Solutions Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Intravenous (IV) Solutions Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Intravenous (IV) Solutions Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Intravenous (IV) Solutions Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Intravenous (IV) Solutions Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Intravenous (IV) Solutions Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Intravenous (IV) Solutions Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Intravenous (IV) Solutions Market Value, 2018 – 2028, (US$ Mn)